Breast fibroadenoma
Conditions
Sponsors
Suining Central Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Gender female; age 18-70 years old; single solid lesion in unilateral breast; breast imaging diagnosis BI-RADS2-3; lesions confirmed by puncture pathology as breast fibroadenoma; lesions 2-5cm size, the focus can be detected by ultrasound; the edge of the focus is more than 2cm from the nipple projection; in the prone position, the focus is located by airborne ultrasound, and the superficial edge is = 1cm from the skin surface. Volunteer to participate in the study, willing to cooperate with the completion of relevant data collection.
Exclusion criteria
Exclusion criteria: The patients in the treatment-related area have received radiotherapy; the patient is pregnant or lactating; the skin in the treatment area has severe scars (protruding the skin surface, width = 1cm); the breast skin in the treatment-related area suffers from infection, ulceration or other skin diseases that affect HIFU treatment; has other malignant tumors and is less than 1 year after the end of treatment; severe cardiopulmonary diseases, can not tolerate prone position for more than 30 minutes. There are surgical taboos; existing breast implants. Those who meet any of the above exclusion criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy (Changes in coagulation necrosis rate and size of lesions);Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life; | — |
Countries
China
Contacts
Public ContactYang Hongwei
Suining Central Hospital
Outcome results
None listed